Geneva: After successfullyhosting the global forum for vaccine sovereign and innovation in collaboration with the African Union and the French Republic, the global vaccine group Gavi announced its agenda and strategic investment plan for the year 2026-2030.

Working towards the future of global immunisation the alliance claims to have vaccinated one billion children between 2000 and 2020 and in its latest plan it is aiming to reach the next billion children in half the time i.e 2030.

In the next five-year strategy, the group also aims to reach at least 50 million children with four doses of the malaria vaccine, and 120 million girls which could potentially save 1.5 million lives with the HPV vaccine.

Presenting its latest investment opportunity Dr Sania Nishtar, CEO, Gavi outlined how the alliance, if fully funded, could protect 500 million children in its next five-year strategic period, saving over 8 million lives.

According to Gavi an estimated cost of US$ nine billion will be required to fund all these initiatives and has urged its various stakeholder donors to support the cause. It will commence its fundraising period, with a view to hosting a final pledging event in the next seven to 12 months as of now the group has received several early pledges from the United States, France, Spain and from some other private sector and philanthropic donors which is estimated “at least US$ 2.4 billion”.

Emmanuel Macron, President, French Republic said, “The Global Forum for Vaccine Sovereignty and Innovation we organized together today in Paris is a concrete milestone towards vaccine sovereignty in Africa. France, hand in hand with its partners, is leading the way to champion global vaccination, ensuring every nation can protect its citizens and foster a healthier, united world.”

“Over twenty years, Gavi has vaccinated a whole generation – over one billion children. Our message today to our donors is that, with their help we can achieve even greater impact, helping to create a world that is safer for everyone,” added José Manuel Barroso, Chair of the Board of Gavi, the Vaccine Alliance.

Advancing its initiatives Gavi and its partners launched “The Starting Line,” a campaign designed to mobilise athletes, content creators, and media to highlight the importance of equal access to vaccines. The campaign will run through this summer’s Paris Olympics and will feature a number of celebrated athletes from different countries.

Meanwhile the global meet also saw the official launch of the African Vaccine Manufacturing Accelerator (AVMA), a programme designed to boost regional vaccine production capabilities in Africa to get better equipped to manage events like pandemics and other health emergencies.

The mechanism has been designed by Gavi in collaboration with the African Union and Africa CDC and will offer incentives to the region’s vaccine producers such as helping to offset high upfront investment costs. In the early stage several sovereign and philanthropic donors committed to provide approximately US$1. 2 billion to AVMA, including around US$ 800 million from Team Europe partners.

Dr Jean Kaseya, Director General, African Centres for Disease Control and Prevention (Africa CDC) said, “Africa CDC supports the replenishment of Gavi’s 6.0 strategy, an investment in preventing deaths from vaccine-preventable diseases in Africa. AVMA will enable us to produce 60 per cent of our vaccines in Africa by 2040. The commitments and pledges for the AVMA mark the beginning of Africa’s journey towards its second independence — an Africa that ensures the health security for its citizens.”

  • Published On Jun 22, 2024 at 06:42 AM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles

Scan to download App